Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation - Trial NCT02064764
Access comprehensive clinical trial information for NCT02064764 through Pure Global AI's free database. This phase not specified trial is sponsored by Medtronic Vascular and is currently Completed. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 102 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Symplicity Spyral™ Multi-Electrode Renal Denervation Catheter
Interventional
device
Sponsor & Location
Medtronic Vascular
Timeline & Enrollment
N/A
Feb 01, 2015
Apr 19, 2021
Primary Outcome
Safety composite events,Rate of chronic treatment success between study arms
Summary
The purpose of this clinical study is to evaluate the feasibility of performing both renal
 nerve denervation and pulmonary vein isolation on the same patient with the intent of
 characterizing both safety and effectiveness in a paroxysmal and persistent atrial
 fibrillation population with hypertension. To assess safety, the study will measure the
 occurrence of a composite safety endpoint and, to assess effectiveness, the study will
 measure freedom of chronic treatment failure through a minimum of six months of follow-up.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02064764
Device Trial